Literature DB >> 17563348

Participant and parent experiences in the parenteral insulin arm of the diabetes prevention trial for type 1 diabetes.

Suzanne Bennett Johnson1, Amy E Baughcum, Korey Hood, Lisa E Rafkin-Mervis, Desmond A Schatz.   

Abstract

OBJECTIVE: To assess participant and parent experiences in the parenteral insulin arm of the Diabetes Prevention Trial for Type 1 Diabetes (DPT-1). RESEARCH DESIGN AND METHODS: Before trial results were publicized, surveys were completed by 82 intervention participants (the intervention group) (who received annual 4-day insulin infusions and daily insulin injections), 81 closely monitored control subjects (the closely monitored group), and 135 parents of children in the trial.
RESULTS: Survey results suggest that participant perspective (adult, child, parent, and sex), study procedures, and group assignment have important implications when planning clinical trials. Parents rated the trial more favorably but worried about hypoglycemia and diabetes onset. Children had the least favorable reaction to the study. Parents preferred assignment to the intervention group; child/adult participants preferred assignment to the closely monitored group. The intervention group rated the annual 4-day insulin infusions more negatively than all other study procedures. Intervention group participants/parents reported poorer insulin injection adherence over the course of the study. Intervention group participants, parents, and female subjects expressed an interest in additional psychosocial support during the trial. Random assignment was viewed negatively by both study groups. Close observation for diabetes onset was viewed as the most favorable aspect of the study. Behaviors outside of the study protocol to prevent or delay diabetes onset were common and should be monitored in future prevention studies.
CONCLUSIONS: Overall, most participants were positive about the trial, and many expressed optimism about the intervention's potential for success. These results have implications for study design, recruitment, and retention procedures in future prevention trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563348     DOI: 10.2337/dc06-2422

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  Recommendations for research success: one investigator's perspective.

Authors:  Suzanne Bennett Johnson
Journal:  J Clin Psychol Med Settings       Date:  2008-02-22

Review 2.  Psychological impact of screening and prediction in type 1 diabetes.

Authors:  Suzanne Bennett Johnson
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

3.  Use of a precious resource: parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetes.

Authors:  Kimberly A Driscoll; Suzanne Bennett Johnson; Desmond A Schatz; Michael J Haller
Journal:  Contemp Clin Trials       Date:  2011-04-17       Impact factor: 2.226

4.  Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes.

Authors:  Suzanne Bennett Johnson; Amy E Baughcum; Lisa E Rafkin-Mervis; Desmond A Schatz
Journal:  Pediatr Diabetes       Date:  2008-09-24       Impact factor: 4.866

5.  From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trial.

Authors:  Eszter Goldstein; Robert Hermann; Timo J Renfors; Kirsti M Näntö-Salonen; Tapio Korhonen; Maarit Kärkkäinen; Riitta K Veijola; Mikael Knip; Tuula T Simell; Olli G Simell
Journal:  Diabetes Care       Date:  2009-09-14       Impact factor: 19.112

6.  Assessment of psychosocial variables by parents of youth with type 1 diabetes mellitus.

Authors:  Fani Eta Korn Malerbi; Carlos Antonio Negrato; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2012-11-22       Impact factor: 3.320

7.  Parental Estimation of Their Child's Increased Type 1 Diabetes Risk During the First 2 Years of Participation in an International Observational Study: Results From the TEDDY study.

Authors:  Ulrica Swartling; Kristian Lynch; Laura Smith; Suzanne Bennett Johnson
Journal:  J Empir Res Hum Res Ethics       Date:  2016-05-30       Impact factor: 1.978

8.  Reasons for Staying as a Participant in the Environmental Determinants of Diabetes in the Young (TEDDY) Longitudinal Study.

Authors:  Barbro Lernmark; Kristian Lynch; Lori Ballard; Judith Baxter; Roswith Roth; Tuula Simell; Suzanne Bennett Johnson
Journal:  J Clin Trials       Date:  2012

9.  Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Authors:  Jay M Sosenko; Jerry P Palmer; Lisa Rafkin-Mervis; Jeffrey P Krischer; David Cuthbertson; Della Matheson; Jay S Skyler
Journal:  Diabetes Care       Date:  2008-07-23       Impact factor: 17.152

10.  Factors associated with maternal-reported actions to prevent type 1 diabetes in the first year of the TEDDY study.

Authors:  Laura B Smith; Kristian F Lynch; Judith Baxter; Barbro Lernmark; Roswith Roth; Tuula Simell; Suzanne Bennett Johnson
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.